PLAINVIEW, NY--(Marketwired - May 04, 2017) -
First Quarter 2017 Highlights:
- Revenues of $94.4 million, up 21% compared with the same period last year
- GAAP earnings per share of $0.03, and non-GAAP earnings per share of $0.09
- Non-GAAP adjusted EBITDA of $7.3 million
- Announced agreement to acquire Ultratech, Inc., a leading supplier of lithography, laser-processing and inspection systems addressing the advanced packaging, semiconductor and LED industries
Veeco Instruments Inc. (
| U.S. dollars in millions, except per share data | ||
| GAAP Results | Q1 '17 | Q1 '16 |
| Revenue | $94.4 | $78.0 |
| Net income (loss) | $1.1 | ($15.5) |
| Diluted earnings (loss) per share | $0.03 | ($0.40) |
| Non-GAAP Results | Q1 '17 | Q1 '16 |
| Net income (loss) | $3.6 | ($5.7) |
| Adjusted EBITDA | $7.3 | ($2.1) |
| Diluted earnings (loss) per share | $0.09 | ($0.15) |
"Veeco's first quarter sales were above seasonal average and increased by more than 20% year-over-year, reflecting a recovery in LED industry conditions. We are continuing to build backlog and see a healthy sales pipeline, which supports top line growth in the second half of 2017. Our Q1 gross margin reflects, among other factors, the temporary impact of our manufacturing consolidation efforts. We now expect to complete these plans in the third quarter. We believe our consolidation efforts combined with sustained cost discipline will drive positive operating leverage, as revenues scale," commented John R. Peeler, Chairman and Chief Executive Officer.
"In addition, we are pleased with the progress we've made towards completing the Ultratech acquisition, which we expect to close in late May. Integration planning is well under way and we expect to hit the ground running on day one," Mr. Peeler concluded.
Guidance and Outlook
The following guidance is provided for Veeco's second quarter 2017:
- Revenue is expected to be in the range of $85 million to $100 million
- Adjusted EBITDA is expected to be in the range of $4 million to $10 million
- GAAP earnings (loss) per share are expected to be in the range of ($0.14) to $0.02 and includes a pre-tax interest expense estimated to be ~$5 million associated with the 2023 Convertible Notes
- Non-GAAP earnings per share are expected to be in the range of ($0.05) to $0.09 and includes a pre-tax interest expense estimated to be ~$2 million associated with the 2023 Convertible Notes
Please refer to the tables at the end of this press release for further details.
Conference Call Information
A conference call reviewing these results has been scheduled for today, May 4, 2017 starting at 5:00pm ET. To join the call, dial 877-741-4251 (toll free) or 719-325-4760 and use passcode 3255654. The call will also be webcast live on the Veeco website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00pm ET this evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.
About Veeco
Veeco's process equipment solutions enable the manufacture of LEDs, displays, power electronics, compound semiconductors, hard disk drives, semiconductors, MEMS and wireless chips. We are the leader in MOCVD, MBE, Ion Beam, Wet Etch single wafer processing and other advanced thin film process technologies. Our high performance systems drive innovation in energy efficiency, consumer electronics and network storage and allow our customers to maximize productivity and achieve lower cost of ownership. For information on our company, products and worldwide service and support, please visit www.veeco.com.
Forward-looking Statements
This written communication contains forward-looking statements that involve risks and uncertainties concerning the proposed acquisition by Veeco Instruments Inc. ("Veeco" or the "Company") of Ultratech, Inc. ("Ultratech"), Ultratech's and the Company's expected financial performance, as well as Ultratech's and the Company's strategic and operational plans. Actual events or results may differ materially from those described in this written communication due to a number of risks and uncertainties. The potential risks and uncertainties include, among others, the possibility that Ultratech may be unable to obtain required stockholder approval or that other conditions to closing the transaction may not be satisfied, such that the transaction will not close or that the closing may be delayed; the reaction of customers to the transaction; general economic conditions; the transaction may involve unexpected costs, liabilities or delays; risks that the transaction disrupts current plans and operations of the parties to the transaction; the ability to recognize the benefits of the transaction; the amount of the costs, fees, expenses and charges related to the transaction and the actual terms of any financings that will be obtained for the transaction; the outcome of any legal proceedings related to the transaction; the occurrence of any event, change or other circumstances that could give rise to the termination of the transaction agreement. In addition, please refer to the documents that the Company and Ultratech file with the Securities and Exchange Commission (the "SEC") on Forms 10-K, 10-Q and 8-K. The filings by the Company and Ultratech identify and address other important factors that could cause its financial and operational results to differ materially from those contained in the forward-looking statements set forth in this written communication.
All forward-looking statements speak only as of the date of this written communication or, in the case of any document incorporated by reference, the date of that document. Neither the Company nor Ultratech is under any duty to update any of the forward-looking statements after the date of this written communication to conform to actual results.
Additional Information and Where to Find It
In connection with the proposed acquisition of Ultratech by Veeco pursuant to the Agreement and Plan of Merger by and among Ultratech, Veeco and Ulysses Acquisition Subsidiary Corp., Veeco filed with the SEC a Registration Statement on Form S-4 on April 24, 2017, which contains a proxy statement of Ultratech and a prospectus of Veeco, which proxy statement/prospectus was mailed or otherwise disseminated to Ultratech's stockholders on April 24, 2017. Investors are urged to read the proxy statement/prospectus (including all amendments and supplements) because they contain important information. Investors may obtain free copies of the proxy statement/prospectus, as well as other filings containing information about Veeco and Ultratech, without charge, at the SEC's Internet site (www.sec.gov). Copies of these documents may also be obtained for free from the companies' web sites at www.Veeco.com or www.Ultratech.com.
Participants in Solicitation
Veeco, Ultratech and their respective officers and directors may be deemed to be participants in the solicitation of proxies from the stockholders of Ultratech in connection with the proposed transaction. Information about Veeco's executive officers and directors is set forth in its Annual Report on Form 10-K, which was filed with the SEC on February 22, 2017, and its proxy statement for its 2017 annual meeting of stockholders, which was filed with the SEC on March 17, 2017. Information about Ultratech's executive officers and directors is set forth in its Annual Report on Form 10-K, which was filed with the SEC on March 1, 2017, and the amendment to its Annual Report on Form 10-K/A, which was filed with the SEC on April 20, 2017. Investors may obtain more detailed information regarding the direct and indirect interests of Veeco, Ultratech and their respective executive officers and directors in the acquisition by reading the proxy statement/prospectus regarding the transaction, which has been filed with the SEC.
| Veeco Instruments Inc. and Subsidiaries | ||||||||
| Condensed Consolidated Statements of Operations | ||||||||
| (in thousands, except per share amounts) | ||||||||
| (unaudited) | ||||||||
| Three months ended March 31, | ||||||||
| 2017 | 2016 | |||||||
| Net sales | $ | 94,386 | $ | 78,011 | ||||
| Cost of sales | 60,186 | 46,055 | ||||||
| Gross profit | 34,200 | 31,956 | ||||||
| Operating expenses, net: | ||||||||
| Research and development | 14,989 | 22,110 | ||||||
| Selling, general, and administrative | 20,466 | 19,839 | ||||||
| Amortization of intangible assets | 2,867 | 5,251 | ||||||
| Restructuring | 1,338 | 100 | ||||||
| Asset impairment | 463 | - | ||||||
| Other, net | (78 | ) | (71 | ) | ||||
| Total operating expenses, net | 40,045 | 47,229 | ||||||
| Operating income (loss) | (5,845 | ) | (15,273 | ) | ||||
| Interest income (expense), net | (3,342 | ) | 268 | |||||
| Income (loss) before income taxes | (9,187 | ) | (15,005 | ) | ||||
| Income tax expense (benefit) | (10,282 | ) | 528 | |||||
| Net income (loss) | $ | 1,095 | $ | (15,533 | ) | |||
| Income (loss) per common share: | ||||||||
| Basic | $ | 0.03 | $ | (0.40 | ) | |||
| Diluted | $ | 0.03 | $ | (0.40 | ) | |||
| Weighted average number of shares: | ||||||||
| Basic | 39,619 | 39,113 | ||||||
| Diluted | 40,140 | 39,113 | ||||||
| Veeco Instruments Inc. and Subsidiaries | ||||||||
| Condensed Consolidated Balance Sheets | ||||||||
| (in thousands) | ||||||||
| March 31, 2017 | December 31, 2016 | |||||||
| (unaudited) | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 423,661 | $ | 277,444 | ||||
| Short-term investments | 258,196 | 66,787 | ||||||
| Accounts receivable, net | 51,433 | 58,020 | ||||||
| Inventories | 64,697 | 77,063 | ||||||
| Deferred cost of sales | 4,684 | 6,160 | ||||||
| Prepaid expenses and other current assets | 19,777 | 16,034 | ||||||
| Total current assets | 822,448 | 501,508 | ||||||
| Property, plant and equipment, net | 63,684 | 60,646 | ||||||
| Intangible assets, net | 55,511 | 58,378 | ||||||
| Goodwill | 114,908 | 114,908 | ||||||
| Deferred income taxes | 4,044 | 2,045 | ||||||
| Other assets | 21,047 | 21,047 | ||||||
| Total assets | $ | 1,081,642 | $ | 758,532 | ||||
| Liabilities and stockholders' equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 30,732 | $ | 22,607 | ||||
| Accrued expenses and other current liabilities | 28,480 | 33,201 | ||||||
| Customer deposits and deferred revenue | 70,785 | 85,022 | ||||||
| Income taxes payable | 2,441 | 2,311 | ||||||
| Current portion of long-term debt | 375 | 368 | ||||||
| Total current liabilities | 132,813 | 143,509 | ||||||
| Deferred income taxes | 14,063 | 13,199 | ||||||
| Long-term debt | 268,098 | 826 | ||||||
| Other liabilities | 1,652 | 6,403 | ||||||
| Total liabilities | 416,626 | 163,937 | ||||||
| Total stockholders' equity | 665,016 | 594,595 | ||||||
| Total liabilities and stockholders' equity | $ | 1,081,642 | $ | 758,532 | ||||
| Veeco Instruments Inc. and Subsidiaries | |||||||||||||||||
| Reconciliation of GAAP to Non-GAAP Financial Data | |||||||||||||||||
| (in thousands, except per share amounts) | |||||||||||||||||
| (unaudited) | |||||||||||||||||
| Non-GAAP Adjustments | |||||||||||||||||
| Three months ended March 31, 2017 |
GAAP | Share-based Compensation | Amortization | Other | Non-GAAP | ||||||||||||
| Net sales | $ | 94,386 | $ | 94,386 | |||||||||||||
| Gross profit | 34,200 | 657 | 89 | 34,946 | |||||||||||||
| Gross margin | 36.2 | % | 37.0 | % | |||||||||||||
| Research and development | 14,989 | (429 | ) | 14,560 | |||||||||||||
| Selling, general, and administrative and Other | 20,388 | (3,100 | ) | (1,361 | ) | 15,927 | |||||||||||
| Net income (loss) | 1,095 | 4,186 | 2,867 | (4,504 | ) | 3,644 | |||||||||||
| Income (loss) per common share: | |||||||||||||||||
| Basic | $ | 0.03 | $ | 0.09 | |||||||||||||
| Diluted | 0.03 | 0.09 | |||||||||||||||
| Weighted average number of shares: | |||||||||||||||||
| Basic | 39,619 | 39,619 | |||||||||||||||
| Diluted | 40,140 | 40,140 | |||||||||||||||
| Veeco Instruments Inc. and Subsidiaries | |||||
| Other Non-GAAP Adjustments | |||||
| (in thousands) | |||||
| (unaudited) | |||||
| Three months ended March 31, 2017 | |||||
| Asset impairment | 463 | ||||
| Restructuring | 1,338 | ||||
| Acquisition related | 1,361 | ||||
| Accelerated depreciation | 89 | ||||
| Non-cash interest expense | 2,185 | ||||
| Non-GAAP tax adjustment * | (9,940 | ) | |||
| Total Other | (4,504 | ) | |||
* - The 'with or without' method is utilized to determine the income tax effect of all non-GAAP adjustments. Also included in the non-GAAP tax adjustment is the exclusion of a $4.9 million tax benefit associated with the Convertible Senior Notes, as well as a $4.9 million tax benefit associated with the reversal of a reserve for an uncertain tax position.
These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.
These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors' operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
| Veeco Instruments Inc. and Subsidiaries | |||||||||||||||||
| Reconciliation of GAAP to Non-GAAP Financial Data | |||||||||||||||||
| (in thousands, except per share amounts) | |||||||||||||||||
| (unaudited) | |||||||||||||||||
| Non-GAAP Adjustments | |||||||||||||||||
| Three months ended March 31, 2016 |
GAAP | Share-based Compensation | Amortization | Other | Non-GAAP | ||||||||||||
| Net sales | $ | 78,011 | $ | 78,011 | |||||||||||||
| Gross profit | 31,956 | 546 | 32,502 | ||||||||||||||
| Gross margin | 41.0 | % | 41.7 | % | |||||||||||||
| Research and development | 22,110 | (1,099 | ) | 21,011 | |||||||||||||
| Selling, general, and administrative and Other | 19,768 | (2,743 | ) | (63 | ) | 16,962 | |||||||||||
| Net income (loss) | (15,533 | ) | 4,388 | 5,251 | 163 | (5,731 | ) | ||||||||||
| Income (loss) per common share: | |||||||||||||||||
| Basic | $ | (0.40 | ) | $ | (0.15 | ) | |||||||||||
| Diluted | (0.40 | ) | (0.15 | ) | |||||||||||||
| Weighted average number of shares: | |||||||||||||||||
| Basic | 39,113 | 39,113 | |||||||||||||||
| Diluted | 39,113 | 39,113 | |||||||||||||||
| Veeco Instruments Inc. and Subsidiaries | ||||
| Other Non-GAAP Adjustments | ||||
| (in thousands) | ||||
| (unaudited) | ||||
| Three months ended March 31, 2016 | ||||
| Restructuring | 100 | |||
| Acquisition Related | 63 | |||
| Total Other | 163 | |||
The 'with or without' method is utilized to determine the income tax effect of all non-GAAP adjustments.
These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.
These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors' operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
| Veeco Instruments Inc. and Subsidiaries | |||||||
| Reconciliation of GAAP Net Income (loss) to Adjusted EBITDA | |||||||
| (in thousands) | |||||||
| (unaudited) | |||||||
| Three months ended March 31, | |||||||
| 2017 | 2016 | ||||||
| GAAP Net income (loss) | $ | 1,095 | $ | (15,533 | ) | ||
| Share-based compensation | 4,186 | 4,388 | |||||
| Amortization | 2,867 | 5,251 | |||||
| Asset impairment | 463 | - | |||||
| Restructuring | 1,338 | 100 | |||||
| Acquisition related | 1,361 | 63 | |||||
| Accelerated depreciation | 89 | - | |||||
| Interest expense (income), net | 3,342 | (268 | ) | ||||
| Depreciation | 2,843 | 3,341 | |||||
| Income tax expense (benefit) | (10,282 | ) | 528 | ||||
| Adjusted EBITDA | $ | 7,302 | $ | (2,130 | ) | ||
This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.
These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors' operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
| Veeco Instruments Inc. and Subsidiaries | |||||||||||
| Reconciliation of GAAP to Non-GAAP Financial Data | |||||||||||
| (in millions, except per share amounts) | |||||||||||
| (unaudited) | |||||||||||
| Non-GAAP Adjustments | |||||||||||
| Guidance for the three months ended June 30, 2017 | GAAP | Share-based Compensation | Amortization | Other | Non-GAAP | ||||||
| Net sales | $85 - $100 | $85 - $100 | |||||||||
| Gross profit | 32 - 39 | 1 | - | - | 33 - 40 | ||||||
| Gross margin | 37% - 39% | 38% - 40% | |||||||||
| Net income (loss) | $(5) - $1 | 4 | 3 | (4) | $(2) - $4 | ||||||
| Income (loss) per diluted common share | $(0.14) - $0.02 | $(0.05) - $0.09 | |||||||||
| Weighted average number of shares | 39 - 40 | 39 - 40 | |||||||||
| Veeco Instruments Inc. and Subsidiaries | ||
| Reconciliation of GAAP Net Income (loss) to Adjusted EBITDA | ||
| (in millions) | ||
| (unaudited) | ||
| Guidance for the three months ended June 30, 2017 | ||
| GAAP Net income (loss) | $(5) - $1 | |
| Share-based compensation | 4 - 4 | |
| Amortization | 3 - 3 | |
| Restructuring | 2 - 2 | |
| Acquisition related | 2 - 2 | |
| Interest expense, net | 4 - 4 | |
| Depreciation | 3 - 3 | |
| Income tax expense (benefit) | (9) - (9) | |
| Adjusted EBITDA | $4 - $10 | |
Note: Amounts may not calculate precisely due to rounding.
These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.
These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors' operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
Contact Information:
Veeco Contacts:
Investors:
Shanye Hudson
516-677-0200 x1272
shudson@veeco.com
Media:
Jeffrey Pina
516-677-0200 x1222
jpina@veeco.com